Lenacapavir is a major step forward in HIV prevention. With just two injections a year, it is a simple and highly effective ...

The Los Angeles County Department of Public Health received notice from the U.S. Centers for Disease Control and Prevention ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

Kelley CF et al. Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. New England Journal of Medicine. November 27, 2024. Alltucker K. FDA Approves New Twice-Yearly HIV Shot.

A non-reactive result in an HIV test generally means that you don't have HIV. It may also mean you tested too soon after ...

"Our team was fully funded through the Ending the HIV Epidemic prevention grant, and without this support, we are unable to ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

"We don't want to shut these doors, we want to make sure they stay open and we can help as many people as we can".